Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Finasteride effectively treats hair loss in transgender men with few side effects.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Moderately high prolactin levels do not cause hair loss in women.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.